Jean F. Voltaire

Array ( [id] => 8209064 [patent_doc_number] => 20120128724 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'SYSTEMS AND METHODS FOR TREATING HUMAN INFLAMMATORY AND PROLIFERATIVE DISEASES AND WOUNDS, WITH FATTY ACID METABOLISM INHIBITORS AND/OR GLYCOLYTIC INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/302211 [patent_app_country] => US [patent_app_date] => 2011-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 52 [patent_no_of_words] => 32143 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20120128724.pdf [firstpage_image] =>[orig_patent_app_number] => 13302211 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9964873 [patent_doc_number] => 09012486 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-21 [patent_title] => 'Topical composition for pain relief' [patent_app_type] => utility [patent_app_number] => 13/295142 [patent_app_country] => US [patent_app_date] => 2011-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3393 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13295142 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9004462 [patent_doc_number] => 20130225587 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-29 [patent_title] => 'COMPOUND FOR INCREASING KINASE ACTIVE AND APPLICATION THEREOF' [patent_app_type] => utility [patent_app_number] => 13/884470 [patent_app_country] => US [patent_app_date] => 2011-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11590 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13884470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8780627 [patent_doc_number] => 20130102602 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-25 [patent_title] => '2-Aryl-4-Quinazolinones And Their Pharmaceutical Compositions' [patent_app_type] => utility [patent_app_number] => 13/277520 [patent_app_country] => US [patent_app_date] => 2011-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9324 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13277520 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7778706 [patent_doc_number] => 20120041067 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'Methods of Inducing Terminal Differentiation' [patent_app_type] => utility [patent_app_number] => 13/276710 [patent_app_country] => US [patent_app_date] => 2011-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 22397 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20120041067.pdf [firstpage_image] =>[orig_patent_app_number] => 13276710 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9691953 [patent_doc_number] => 08822549 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-02 [patent_title] => 'Buffered oxygen therapeutic' [patent_app_type] => utility [patent_app_number] => 13/273115 [patent_app_country] => US [patent_app_date] => 2011-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 5814 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13273115 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8382294 [patent_doc_number] => 20120225919 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-06 [patent_title] => 'Compositions and Methods for Non-Surgical Treatment of Ptosis' [patent_app_type] => utility [patent_app_number] => 13/270577 [patent_app_country] => US [patent_app_date] => 2011-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12618 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13270577 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9082028 [patent_doc_number] => 20130267558 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-10 [patent_title] => 'PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING ALCOHOLIC LIVER DISEASES, CONTAINING CILOSTAZOL AS ACTIVE INGREDIENT' [patent_app_type] => utility [patent_app_number] => 13/880792 [patent_app_country] => US [patent_app_date] => 2011-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3907 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13880792 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8738400 [patent_doc_number] => 08410170 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-02 [patent_title] => 'Use of isothiocyanates compounds in treating prostatic diseases and skin cancer' [patent_app_type] => utility [patent_app_number] => 13/231406 [patent_app_country] => US [patent_app_date] => 2011-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 19 [patent_no_of_words] => 16042 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13231406 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8738400 [patent_doc_number] => 08410170 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-02 [patent_title] => 'Use of isothiocyanates compounds in treating prostatic diseases and skin cancer' [patent_app_type] => utility [patent_app_number] => 13/231406 [patent_app_country] => US [patent_app_date] => 2011-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 19 [patent_no_of_words] => 16042 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13231406 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8336079 [patent_doc_number] => 20120202789 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-09 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 13/224722 [patent_app_country] => US [patent_app_date] => 2011-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 22391 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13224722 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9127242 [patent_doc_number] => 08575191 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-05 [patent_title] => 'Methods for treatment of non-small cell lung cancer' [patent_app_type] => utility [patent_app_number] => 13/222174 [patent_app_country] => US [patent_app_date] => 2011-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 24833 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13222174 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7818635 [patent_doc_number] => 20120065255 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-15 [patent_title] => 'CABAZITAXEL FORMULATIONS AND METHODS OF PREPARING THEREOF' [patent_app_type] => utility [patent_app_number] => 13/207334 [patent_app_country] => US [patent_app_date] => 2011-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7048 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20120065255.pdf [firstpage_image] =>[orig_patent_app_number] => 13207334 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10888232 [patent_doc_number] => 08912228 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-16 [patent_title] => 'Docetaxel formulations with lipoic acid' [patent_app_type] => utility [patent_app_number] => 13/207339 [patent_app_country] => US [patent_app_date] => 2011-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5515 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13207339 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7580938 [patent_doc_number] => 20110294821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => '5-HT1A RECEPTOR SUBTYPE AGONIST' [patent_app_type] => utility [patent_app_number] => 13/195954 [patent_app_country] => US [patent_app_date] => 2011-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4675 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294821.pdf [firstpage_image] =>[orig_patent_app_number] => 13195954 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7580938 [patent_doc_number] => 20110294821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => '5-HT1A RECEPTOR SUBTYPE AGONIST' [patent_app_type] => utility [patent_app_number] => 13/195954 [patent_app_country] => US [patent_app_date] => 2011-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4675 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294821.pdf [firstpage_image] =>[orig_patent_app_number] => 13195954 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7580938 [patent_doc_number] => 20110294821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => '5-HT1A RECEPTOR SUBTYPE AGONIST' [patent_app_type] => utility [patent_app_number] => 13/195954 [patent_app_country] => US [patent_app_date] => 2011-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4675 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294821.pdf [firstpage_image] =>[orig_patent_app_number] => 13195954 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7580938 [patent_doc_number] => 20110294821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => '5-HT1A RECEPTOR SUBTYPE AGONIST' [patent_app_type] => utility [patent_app_number] => 13/195954 [patent_app_country] => US [patent_app_date] => 2011-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4675 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294821.pdf [firstpage_image] =>[orig_patent_app_number] => 13195954 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7778311 [patent_doc_number] => 20120040925 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'ARYL UREA COMPOUNDS IN COMBINATION WITH OTHER CYTOSTATIC OR CYTOTOXIC AGENTS FOR TREATING HUMAN CANCERS' [patent_app_type] => utility [patent_app_number] => 13/189945 [patent_app_country] => US [patent_app_date] => 2011-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9302 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20120040925.pdf [firstpage_image] =>[orig_patent_app_number] => 13189945 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9286270 [patent_doc_number] => 08642600 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-04 [patent_title] => 'Method of treating autism' [patent_app_type] => utility [patent_app_number] => 13/185879 [patent_app_country] => US [patent_app_date] => 2011-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4747 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13185879 [rel_patent_id] =>[rel_patent_doc_number] =>)